...
evgn-img

Evogene, Common Stock

EVGN

NAQ

$1.32

-$0.05

(-3.65%)

1D
Industry: Biotechnology Sector: Health Care

Analyst Forecast

Price Chart

Key Metrics

Market Cap info-icon
This is a company’s total value as determined by the stock market. It is calculated by multiplying the total number of a company's outstanding shares by the current market price of one share.
$9.76M
P/E Ratio info-icon
This is the ratio of a security’s current share price to its earnings per share. This ratio determines the relative value of a company’s share.
0
Volume info-icon
This is the total number of shares traded during the most recent trading day.
39.42K
Avg Volume info-icon
This is the average number of shares traded during the most recent 30 days.
0
Dividend Yield info-icon
This ratio shows how much income you earn in dividend payouts per year for every dollar invested in the stock (or the stock’s annual dividend payment expressed as a percentage of its current price).
0.00%
Beta info-icon
This measures the expected move in a stock’s price relative to movements in the overall market. The market, such as the S&P 500 Index, has a beta of 1.0. If a stock has a Beta greater (or lower) than 1.0, it suggests that the stock is more (or less) volatile than the broader market.
1.08
52-week Range info-icon
This shows the range of the stock’s price between the 52-week high (the highest price of the stock for the past 52 weeks) and the 52-week low (the lowest price of the stock for the past 52 weeks).
$1.26 L
$10.4 H
$1.32

About Evogene, Common Stock

Evogene Ltd., together with its subsidiaries, operates as a computational biology company. It focuses on product discovery and development in life-science based industries, including human health, agriculture, and other industrial applications through the use of its Computational Predictive Biology (CPB) platform. The company operates through three segments: Agriculture, Human Health, and Industrial Applications. The Agriculture segment develops seed traits, ag-chemical products, and ag-biological products to enhance plant performance. The Human Health segment discovers and develops human microbiome-based therapeutics for the treatment of immuno-oncology, gastrointestinal inflammatory related disorders, and antimicrobial resistance organisms. The Industrial Applications segment develops enhanced castor bean seeds to serve as a feedstock source for other industrial uses. The company also provides medical cannabis products. It operates in the United States, Israel, Brazil, and internationally. Evogene Ltd. was founded in 1999 and is headquartered in Rehovot, Israel. more

Industry: BiotechnologySector: Health Care

Returns

Time FrameEVGNSectorS&P500
1-Week Return-13.16%-3.72%-0.05%
1-Month Return-21.43%-1.85%2.75%
3-Month Return-56%-11.4%7.4%
6-Month Return-79.55%-4.41%10.47%
1-Year Return-80.3%4.13%27.57%
3-Year Return-92.75%0.3%29.56%
5-Year Return-90.83%36.62%89.3%
10-Year Return-98.7%106.81%206.09%

Financials

Dec '19Dec '20Dec '21Dec '22Dec '235YR TREND
Total Revenue753.00K1.04M930.00K1.68M5.64M[{"date":"2019-12-31","value":13.35,"profit":true},{"date":"2020-12-31","value":18.44,"profit":true},{"date":"2021-12-31","value":16.49,"profit":true},{"date":"2022-12-31","value":29.7,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Cost of Revenue334.00K574.00K767.00K909.00K4.24M[{"date":"2019-12-31","value":7.88,"profit":true},{"date":"2020-12-31","value":13.53,"profit":true},{"date":"2021-12-31","value":18.09,"profit":true},{"date":"2022-12-31","value":21.43,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Gross Profit419.00K466.00K163.00K766.00K1.40M[{"date":"2019-12-31","value":29.95,"profit":true},{"date":"2020-12-31","value":33.31,"profit":true},{"date":"2021-12-31","value":11.65,"profit":true},{"date":"2022-12-31","value":54.75,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Gross Margin55.64%44.81%17.53%45.73%24.80%[{"date":"2019-12-31","value":100,"profit":true},{"date":"2020-12-31","value":80.53,"profit":true},{"date":"2021-12-31","value":31.5,"profit":true},{"date":"2022-12-31","value":82.19,"profit":true},{"date":"2023-12-31","value":44.58,"profit":true}]
Operating Expenses21.59M25.28M31.12M27.71M27.79M[{"date":"2019-12-31","value":69.37,"profit":true},{"date":"2020-12-31","value":81.24,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":89.04,"profit":true},{"date":"2023-12-31","value":89.31,"profit":true}]
Operating Income(21.17M)(24.81M)(30.95M)(26.94M)(26.39M)[{"date":"2019-12-31","value":-2116600000,"profit":false},{"date":"2020-12-31","value":-2481400000,"profit":false},{"date":"2021-12-31","value":-3095300000,"profit":false},{"date":"2022-12-31","value":-2694100000,"profit":false},{"date":"2023-12-31","value":-2639100000,"profit":false}]
Total Non-Operating Income/Expense2.48M(2.72M)1.04M(2.13M)3.22M[{"date":"2019-12-31","value":77.02,"profit":true},{"date":"2020-12-31","value":-84.47,"profit":false},{"date":"2021-12-31","value":32.36,"profit":true},{"date":"2022-12-31","value":-66.02,"profit":false},{"date":"2023-12-31","value":100,"profit":true}]
Pre-Tax Income(19.09M)(26.17M)(30.43M)(29.75M)(25.99M)[{"date":"2019-12-31","value":-1909100000,"profit":false},{"date":"2020-12-31","value":-2617400000,"profit":false},{"date":"2021-12-31","value":-3043200000,"profit":false},{"date":"2022-12-31","value":-2975400000,"profit":false},{"date":"2023-12-31","value":-2598700000,"profit":false}]
Income Taxes24.00K32.00K13.00K90.00K(33.00K)[{"date":"2019-12-31","value":26.67,"profit":true},{"date":"2020-12-31","value":35.56,"profit":true},{"date":"2021-12-31","value":14.44,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":-36.67,"profit":false}]
Income After Taxes(19.11M)(26.21M)(30.45M)(29.84M)(25.95M)[{"date":"2019-12-31","value":-1911500000,"profit":false},{"date":"2020-12-31","value":-2620600000,"profit":false},{"date":"2021-12-31","value":-3044500000,"profit":false},{"date":"2022-12-31","value":-2984400000,"profit":false},{"date":"2023-12-31","value":-2595400000,"profit":false}]
Income From Continuous Operations(19.11M)(26.21M)(30.45M)(29.84M)(22.44M)[{"date":"2019-12-31","value":-1911500000,"profit":false},{"date":"2020-12-31","value":-2620600000,"profit":false},{"date":"2021-12-31","value":-3044500000,"profit":false},{"date":"2022-12-31","value":-2984400000,"profit":false},{"date":"2023-12-31","value":-2243800000,"profit":false}]
Income From Discontinued Operations-----[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Net Income(19.11M)(23.37M)(27.79M)(26.64M)(23.88M)[{"date":"2019-12-31","value":-1911500000,"profit":false},{"date":"2020-12-31","value":-2337400000,"profit":false},{"date":"2021-12-31","value":-2779300000,"profit":false},{"date":"2022-12-31","value":-2663800000,"profit":false},{"date":"2023-12-31","value":-2387900000,"profit":false}]
EPS (Diluted)(0.71)(0.82)(0.69)(0.64)(0.53)[{"date":"2019-12-31","value":-71,"profit":false},{"date":"2020-12-31","value":-82,"profit":false},{"date":"2021-12-31","value":-69,"profit":false},{"date":"2022-12-31","value":-64,"profit":false},{"date":"2023-12-31","value":-53,"profit":false}]

Ratios

Liquidity

These ratios help you determine the liquidity of the company. Higher is better.

EVGN
Cash Ratio 0.86
Current Ratio 1.09
Quick Ratio 1.03

Asset Efficiency

These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.

EVGN
ROA (LTM) -28.46%
ROE (LTM) -82.37%

Liabilities

These ratios help you understand the company's liabilities, gauging the riskiness of the investment.

EVGN
Debt Ratio Lower is generally better. Negative is bad. 0.69
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. -0.11

Valuation

These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.

EVGN
Trailing PE NM
Forward PE NM
P/S (TTM) 1.03
P/B 4.71
Price/FCF NM
EV/R 0.11
EV/Ebitda NM
PEG NM

FAQs

What is Evogene share price today?

Evogene (EVGN) share price today is $1.32

Can Indians buy Evogene shares?

Yes, Indians can buy shares of Evogene (EVGN) on Vested. To buy Evogene from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in EVGN stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.

Can Fractional shares of Evogene be purchased?

Yes, you can purchase fractional shares of Evogene (EVGN) via the Vested app. You can start investing in Evogene (EVGN) with a minimum investment of $1.

How to invest in Evogene shares from India?

You can invest in shares of Evogene (EVGN) via Vested in three simple steps:

  • Click on Sign Up or Invest in EVGN stock at the top of this page
  • Breeze through our fully digital and secure KYC process and open your US Brokerage account in a few minutes
  • Transfer USD funds to your US Brokerage account and start investing in Evogene shares
What is Evogene 52-week high and low stock price?

The 52-week high price of Evogene (EVGN) is $10.4. The 52-week low price of Evogene (EVGN) is $1.26.

What is Evogene price-to-earnings (P/E) ratio?

The price-to-earnings (P/E) ratio of Evogene (EVGN) is

What is Evogene price-to-book (P/B) ratio?

The price-to-book (P/B) ratio of Evogene (EVGN) is 4.71

What is Evogene dividend yield?

The dividend yield of Evogene (EVGN) is 0.00%

What is the Market Cap of Evogene?

The market capitalization of Evogene (EVGN) is $9.76M

What is Evogene’s stock symbol?

The stock symbol (or ticker) of Evogene is EVGN

Signup to access all features and start your US investing journey!

  • Open your account in minutes
  • Take your portfolio global, starting at just $1
Get started

Add ticker to compare

Scroll to Top